Pain-O-Soma 500 mg HAB Pharmaceuticals

£12.00

Carisoprodol 500mg research tablets from HAB Pharmaceuticals for laboratory investigation. High-purity pharmaceutical-grade compound for muscle relaxant mechanism studies.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Pain-O-Soma 500 mg HAB Pharmaceuticals
Pain-O-Soma 500 mg HAB Pharmaceuticals
£12.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Pain-O-Soma Carisoprodol Research Overview

Carisoprodol is a centrally acting muscle relaxant pharmaceutical compound extensively studied in neuropharmacological research. These Pain-O-Soma 500mg tablets from HAB Pharmaceuticals provide researchers with pharmaceutical-grade carisoprodol for investigating skeletal muscle relaxation mechanisms and central nervous system modulation pathways. Laboratory scientists can examine this compound’s unique pharmacokinetic profile and metabolic conversion to meprobamate in controlled research environments.

Our Stroid UK Shop maintains stringent quality standards for all pharmaceutical compounds, ensuring researchers receive authentic HAB Pharmaceuticals formulations. The Pain-O-Soma brand represents a well-documented carisoprodol preparation suitable for comparative pharmacological studies alongside other muscle relaxant compounds available in our carisoprodol research collection.

Laboratory Research Applications

Research teams investigate carisoprodol’s mechanism of action through GABAergic neurotransmitter system modulation studies. The compound demonstrates interesting pharmacological properties as both a muscle relaxant and anxiolytic agent in preclinical models. Scientists examine its rapid onset kinetics and biotransformation pathways, particularly the formation of active metabolites including meprobamate and hydroxycarisoprodol.

Contemporary research focuses on carisoprodol’s interaction with gamma-aminobutyric acid receptors and voltage-gated sodium channels. Laboratory investigations compare its efficacy profile against other centrally acting muscle relaxants, while pharmacokinetic studies examine its absorption, distribution, and elimination characteristics. Researchers also explore potential drug interaction pathways relevant to polysubstance pharmacology studies.

Cross-disciplinary research teams studying muscle relaxation mechanisms often incorporate carisoprodol alongside investigations of selective androgen receptor modulators and peptide compounds to understand comprehensive muscle function and recovery pathways.

Product Specifications

Pain-O-Soma 500mg Research Tablet Specifications
Parameter Specification
Active Ingredient Carisoprodol 500mg
Manufacturer HAB Pharmaceuticals
Formulation Film-coated tablets
CAS Registry 78-44-4
Molecular Formula C₁₂H₂₄N₂O₄
Molecular Weight 260.33 g/mol
Storage Conditions Room temperature, dry environment
Research Classification Centrally acting muscle relaxant

Research Compliance Statement

Pain-O-Soma 500mg tablets are supplied exclusively for in-vitro laboratory research purposes. This pharmaceutical compound is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must comply with all applicable regulations governing pharmaceutical research materials and maintain appropriate laboratory safety protocols when handling this compound. All studies should be conducted by qualified research personnel in licensed laboratory facilities with proper documentation and safety measures.

Related